Current appraisal of conjunctival melanocytic tumors: Classification and treatment

Future Oncology

Volumn 7, Issue 3, 2011, Pages 435-446

  Harooni, Hooman ^a   Schoenfield, Lynn R ^a   Singh, Arun D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

conjunctiva; melanoma; melanoma in situ; nevus; primary acquired melanosis

Indexed keywords

COBALT 60; IODINE 125; MELANIN; MITOMYCIN C; MONOCLONAL ANTIBODY HMB 45; RUTHENIUM 106; STRONTIUM 90;

BIOPSY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CATARACT; CONJUNCTIVA; CONJUNCTIVA MELANOCYTIC INTRAEPITHELIAL NEOPLASIA; CONJUNCTIVA MELANOCYTIC TUMOR; CONJUNCTIVA TUMOR; CRYOTHERAPY; DISEASE CLASSIFICATION; DRY EYE; EOSINOPHIL; ETHNICITY; FOLLOW UP; GLAUCOMA; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; KERATOPATHY; LYMPH NODE METASTASIS; LYMPHOCYTE; MELANOCYTE; MELANOCYTOSIS; MELANOMA; MELANOSIS; MORTALITY; NEVUS CELL; PIGMENTED NEVUS; PLASMA CELL; PRIMARY ACQUIRED MELANOSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SENTINEL LYMPH NODE; SLIT LAMP; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; ULCER; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; CONJUNCTIVAL NEOPLASMS; HUMANS; MELANOMA; MELANOSIS; NEVUS, PIGMENTED; PROGNOSIS;

EID: 79953154275     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.11.12     Document Type: Review

References (68)

1. Peer J: Examination techniques, classification, and differential diagnosis of conjunctival and corneal tumors. In: Clinical Ophthalmic Oncology. Vol 1. Singh AD, Damato BE, Peer J, Murphree AL, Perry JD (Eds). Elsevier, PA, USA 125-128 (2007).
2. Shields CL, Demirci H, Karatza E, Shields JA: Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 111(9), 1747-1754 (2004). (Pubitemid 39179692)
3. Shields CL, Shields JA: Tumors of the conjunctiva and cornea. Surv. Ophthalmol. 49(1), 3-24 (2004). (Pubitemid 38056621)
4. Kurli M, Finger PT: Melanocytic conjunctival tumors. Ophthalmol. Clin. North Am. 18(1), 15-24, VII (2005). (Pubitemid 40348807)
5. Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T: Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology 96(4), 436-461 (1989). (Pubitemid 19101645)
6. Jakobiec FA, Bhat P, Colby KA: Immunohistochemical studies of conjunctival nevi and melanomas. Arch. Ophthalmol. 128(2), 174-183 (2010).
7. Gerner N, Norregaard JC, Jensen OA, Prause JU: Conjunctival naevi in Denmark 1960-1980. A 21-year follow-up study. Acta Ophthalmol. Scand. 74(4), 334-337 (1996). (Pubitemid 26319446)
8. Zamir E, Mechoulam H, Micera A, Levi-Schaffer F, Peer J: Inflamed juvenile conjunctival naevus: clinicopathological characterisation. Br. J. Ophthalmol. 86(1), 28-30 (2002). (Pubitemid 34074879)
9. Folberg R, McLean IW, Zimmerman LE: Conjunctival melanosis and melanoma. Ophthalmology 91(6), 673-678 (1984). (Pubitemid 14120069)
10. Damato B, Coupland SE: Management of conjunctival melanoma. Expert Rev. Anticancer Ther. 9(9), 1227-1239 (2009).
11. Folberg R, McLean IW, Zimmerman LE: Primary acquired melanosis of the conjunctiva. Hum. Pathol. 16(2), 129-135 (1985). (Pubitemid 15136923)
12. Shields JA, Shields CL, Mashayekhi A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans. Am. Ophthalmol. Soc. 105, 61-71; discussion 71-62 (2007). (Pubitemid 352031814)
13. Griffith WR, Green WR, Weinstein GW: Conjunctival malignant melanoma originating in acquired melanosis sine pigmento. Am. J. Ophthalmol. 72(3), 595-599 (1971).
14. Singh AD, Campos OE, Rhatigan RM, Schulman JA, Misra RP: Conjunctival melanoma in the black population. Surv. Ophthalmol. 43(2), 127-133 (1998). (Pubitemid 28460021)
15. Colby KA, Nagel DS: Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman. Cornea 24(3), 352-355 (2005). (Pubitemid 40418351)
16. Novais GA, Fernandes BF, Belfort RN, Castiglione E, Cheema DP, Burnier MN Jr: Incidence of melanocytic lesions of the conjunctiva in a review of 10675 ophthalmic specimens. Int. J. Surg. Pathol.-18(1), 60-63 (2010).
17. Jakobiec FA, Folberg R, Iwamoto T: Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 96(2), 147-166 (1989). (Pubitemid 19049454)
18. Malignant melanoma of the conjunctiva. In: AJCC Cancer Staging Manual (7th Edition). Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds). Spinger, USA (2010).
19. Sugiura M, Colby KA, Mihm MC Jr, Zembowicz A: Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases. Am. J. Surg. Pathol. 31(2), 185-192 (2007). (Pubitemid 46175018)
20. Damato B, Coupland SE: Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin. Experiment. Ophthalmol. 36(8), 786-795 (2008).
21. Chalasani R, Giblin M, Conway RM: Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin. Experiment. Ophthalmol. 34(7), 708-714 (2006). (Pubitemid 44363625)
22. Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S: Time trends in the incidence of conjunctival melanoma in Sweden. Br. J. Ophthalmol. 93(11), 1524-1528 (2009).
23. Kujala E, Tuomaala S, Eskelin S, Kivela T: Mortality after uveal and conjunctival melanoma: which tumour is more deadly? Acta Ophthalmol. (2009) 87(2), 149-153.
24. Isager P, Engholm G, Overgaard J, Storm H: Uveal and conjunctival malignant melanoma in denmark 1943-1997: observed and relative survival of patients followed through 2002. Ophthal. Epidemiol. 13(2), 85-96 (2006).
25. Yu GP, Hu DN, McCormick S, Finger PT: Conjunctival melanoma: is it increasing in the United States? Am. J. Ophthalmol. 135(6), 800-806 (2003). (Pubitemid 36677397)
26. Inskip PD, Devesa SS, Fraumeni JF Jr: Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 14(3), 251-257 (2003). (Pubitemid 36656335)
27. Hu DN, Yu G, McCormick SA, Finger PT: Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am. J. Ophthalmol. 145(3), 418-423 (2008).
28. Seregard S, Kock E: Conjunctival malignant melanoma in Sweden 1969-1991. Acta Ophthalmol. 70(3), 289-296 (1992).
29. Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D: Conjunctival melanoma in The Netherlands: a nationwide study. Invest. Ophthalmol. Vis. Sci. 46(1), 75-82 (2005). (Pubitemid 40041181)
30. Peer J, Folberg R: Conjunctival melanoma. In: Clinical Ophthalmic Oncology. Volume 1. Singh AD, Damato BE, Peer J, Murphree AL, Perry JD (Eds). Elsevier, PA, USA 146-149 (2007).
31. Shields CL: Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am. Ophthalmol. Soc. 98, 471-492 (2000). (Pubitemid 32059519)
32. Baum TD, Adamis AP, Jakobiec FA: Primary acquired melanosis of the conjunctiva. Int. Ophthalmol. Clin. 37(4), 61-72 (1997). (Pubitemid 28016287)
33. Galor A, Jeng BH, Singh AD: Surgical techniques. In: Clinical Ophthalmic Oncology. Volume 1. Singh AD, Damato BE, Murphee AL, Perry JD (Eds). Saunders-Elsevier, PA, USA, 158-161 (2007).
34. Shields CL, Shields JA, Armstrong T: Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am. J. Ophthalmol. 132(4), 576-578 (2001). (Pubitemid 32904587)
35. Stannard CE, Sealy GR, Hering ER, Pereira SB, Knowles R, Hill JC: Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology 107(5), 951-958 (2000).
36. Zehetmayer M, Menapace R, Kulnig W: Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. Ophthalmologica 207(3), 133-139 (1993). (Pubitemid 24001981)
37. Shields JA, Shields CL, Gunduz K, Cater J: Clinical features predictive of orbital exenteration for conjunctival melanoma. Ophthal. Plast. Reconstr. Surg. 16(3), 173-178 (2000). (Pubitemid 32115302)
38. Wuestemeyer H, Sauerwein W, Meller D, et al. Proton radiotherapy as an alternative to exenteration in the managementf extended conjunctival melanoma. Ophthalmologie 244(4), 438-446 (2006).
39. Tatla T, Hungerford J, Plowman N, Ghufoor K, Keene M: Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease. Laryngoscope 115(5), 817-822 (2005). (Pubitemid 40604686)
40. Travis LW, Rice DH, McClatchey KD, Wallace SW: Malignant melanoma of conjunctiva metastatic to parotid gland. Reports of cases and discussion of surgical management. Laryngoscope 87(12), 2000-2007 (1977).
41. Paridaens AD, McCartney AC, Minassian DC, Hungerford JL: Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br. J. Ophthalmol. 78(7), 520-528 (1994). (Pubitemid 24213009)
42. Esmaeli B, Wang X, Youssef A, Gershenwald JE: Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology 108(11), 2101-2105 (2001). (Pubitemid 33032786)
43. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch. Ophthalmol. 118(11), 1497-1507 (2000).
44. Tuomaala S, Kivela T: Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 111(4), 816-821 (2004). (Pubitemid 38429682)
45. Amato M, Esmaeli B, Ahmadi MA, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal. Plast. Reconstr. Surg. 19(2), 102-106 (2003). (Pubitemid 36348962)
46. Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B: Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch. Otolaryngol. Head Neck Surg. 133(8), 820-826 (2007). (Pubitemid 47295766)
47. Tuomaala S, Eskelin S, Tarkkanen A, Kivela T: Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest. Ophthalmol. Vis. Sci. 43(11), 3399-3408 (2002). (Pubitemid 35334346)
48. Werschnik C, Lommatzsch PK: Long-term follow-up of patients with conjunctival melanoma. Am. J. Clin. Oncol. 25(3), 248-255 (2002). (Pubitemid 34602545)
49. Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH: Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J. Cutan. Pathol. 37(2), 196-203 (2010).
50. Wilson MW, Schelonka LP, Siegel D, Meininger A, Ross D: Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis. Curr. Eye Res. 22(5), 348-352 (2001). (Pubitemid 34248294)
51. Flaherty KT, Hodi FS, Bastian BC: Mutation-driven drug development in melanoma. Curr. Opin. Oncol. 22(3), 178-183 (2010).
52. Populo H, Soares P, Rocha AS, Silva P, Lopes JM: Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma. Melanoma Res. 20(2), 107-117 (2010).
53. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin. Cancer Res. 14(21), 6821-6828 (2008).
54. Curtin JA, Busam K, Pinkel D, Bastian BC: Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24(26), 4340-4346 (2006). (Pubitemid 46630793)
55. Satzger I, Schaefer T, Kuettler U, et al. Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br. J. Cancer 99(12), 2065-2069 (2008).
56. Hodi FS, Friedlander P, Corless CL, et al. Major response to imatinib mesylate in KIT-mutated melanoma. J. Clin. Oncol. 26(12), 2046-2051 (2008).
57. Lutzky J, Bauer J, Bastian BC: Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation. Pigment Cell Melanoma Res. 21(4), 492-493 (2008). (Pubitemid 351990966)
58. Kurli M, Finger PT: Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years? experience. Ophthalmologie 243(11), 1108-1114 (2005). (Pubitemid 43124161)
59. Peer J, Frucht-Pery J: The treatment of primary acquired melanosis (PAM) with atypia by topical mitomycin C. Am. J. Ophthalmol. 139(2), 229-234 (2005). (Pubitemid 40288265)
60. Kemp EG, Harnett AN, Chatterjee-: Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Br. J. Ophthalmol. 86(1), 31-34 (2002). (Pubitemid 34074880)
61. Yuen VH, Jordan DR, Brownstein S, Dorey MW: Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. Ophthal. Plast. Reconstr. Surg. 19(2), 149-151 (2003). (Pubitemid 36348971)
62. Rodriguez-Ares T, Tourino R, De Rojas V, Becerra E, Capeans C: Topical mitomycin C in the treatment of pigmented conjunctival lesions. Cornea 22(2), 114-117 (2003). (Pubitemid 36701911)
63. Walsh-Conway N, Conway RM: Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin. Experiment. Ophthalmol. 37(6), 577-583 (2009).
64. Krause L, Ritter C, Wachtlin J, et al. Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma. Klin. Monbl. Augenheilkd. 225(7), 649-652 (2008).
65. Zografos L, Uffer S, Bercher L, Gailloud C: Combined surgery, cryocoagulation and radiotherapy for treatment of melanoma of the conjunctiva. Klin. Monbl. Augenheilkd. 204(5), 385-390 (1994). (Pubitemid 24199373)
66. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P: Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br. J. Ophthalmol. 74(10), 615-619 (1990). (Pubitemid 20302797)
67. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL: Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br. J. Ophthalmol. 78(4), 252-259 (1994). (Pubitemid 24114163)
68. Tuomaala S, Toivonen P, Al-Jamal R, Kivela T: Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr. Eye Res. 32(11), 939-952 (2007). (Pubitemid 350135723)